Evidence map›Paper›PMID 37511986›Full record

ArticleLife (Basel, Switzerland)2023

Antiviral Potential of Specially Selected Bulgarian Propolis Extracts: In Vitro Activity against Structurally Different Viruses.

Neli Milenova Vilhelmova-Ilieva, Ivanka Nikolova Nikolova, Nadya Yordanova Nikolova, Zdravka Dimitrova Petrova, Madlena Stephanova Trepechova, Dora Ilieva Holechek, Mina Mihaylova Todorova, Mariyana Georgieva Topuzova, Ivan Georgiev Ivanov, Yulian Dimitrov Tumbarski

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Bee products as alternatives in the treatment of viral infections.Journal of the science of food and agriculture · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Neli Milenova Vilhelmova-IlievaDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0003-4772-4471
Ivanka Nikolova NikolovaDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0001-9130-6600
Nadya Yordanova NikolovaDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev Str., 1113 Sofia, Bulgaria.
Zdravka Dimitrova PetrovaDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev Str., 1113 Sofia, Bulgaria.
Madlena Stephanova TrepechovaDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev Str., 1113 Sofia, Bulgaria.
Dora Ilieva HolechekDepartment of Virology, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev Str., 1113 Sofia, Bulgaria.
Mina Mihaylova TodorovaDepartment of Organic Chemistry, Paisii Hilendarski University of Plovdiv, 24 Tsar Asen Str., 4000 Plovdiv, Bulgaria.
Mariyana Georgieva TopuzovaDepartment of Organic Chemistry and Inorganic Chemistry, University of Food Technologies, 26 Maritsa blvd., 4002 Plovdiv, Bulgaria.
Ivan Georgiev IvanovDepartment of Organic Chemistry and Inorganic Chemistry, University of Food Technologies, 26 Maritsa blvd., 4002 Plovdiv, Bulgaria.ORCID 0000-0002-6826-2723
Yulian Dimitrov TumbarskiDepartment of Microbiology, University of Food Technologies, 26 Maritsa blvd., 4002 Plovdiv, Bulgaria.
Bulgarian Academy of Sciences · BGUniversity of Food Technologies · BGPlovdiv University · BG

Funding

Bulgarian Science Fund КП-06-ДК1/3
6 · The paper itself

Abstract

Propolis is a natural mixture of resins, wax, and pollen from plant buds and flowers, enriched with enzymes and bee saliva. It also contains various essential oils, vitamins, mineral salts, trace elements, hormones, and ferments. It has been found that propolis possesses antimicrobial, antiviral, and anti-inflammatory properties. We have studied the antiviral activity of six extracts of Bulgarian propolis collected from six districts of Bulgaria. The study was conducted against structurally different viruses: human coronavirus strain OC-43 (HCoV OC-43) and human respiratory syncytial virus type 2 (HRSV-2) (enveloped RNA viruses), human herpes simplex virus type 1 (HSV-1) (enveloped DNA virus), human rhinovirus type 14 (HRV-14) (non-enveloped RNA virus) and human adenovirus type 5 (HadV-5) (non-enveloped DNA virus). The influence of the extracts on the internal replicative cycle of viruses was determined using the cytopathic effect (CPE) inhibition test. The virucidal activity, its impact on the stage of viral adsorption to the host cell, and its protective effect on healthy cells were evaluated using the final dilution method, making them the focal points of interest. The change in viral infectivity under the action of propolis extracts was compared with untreated controls, and Δlgs were determined. Most propolis samples administered during the viral replicative cycle demonstrated the strongest activity against HCoV OC-43 replication. The influence of propolis extracts on the viability of extracellular virions was expressed to a different degree in the various viruses studied, and the effect was significantly stronger in those with an envelope. Almost all extracts significantly inhibited the adsorption step of the herpes virus and, to a less extent, of the coronavirus to the host cell, and some of them applied before viral infection demonstrated a protective effect on healthy cells. Our results enlarge the knowledge about the action of propolis and could open new perspectives for its application in viral infection treatment.

Indexed as

antiviral activityherpes simplex virushuman adenovirushuman coronavirushuman respiratory syncytial virushuman rhinoviruspropolis extractsviral adsorptionvirucidal activity

Identifiers

PMID37511986
PMCPMC10381642
OpenAlexW4385215837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.